Dergiler / Perinatal journal (Online) / 2022 / Cilt: 30 - Sayı: 2

The effect of COVID-19 infection on hematological parameters and early pregnancy loss

Sayfa
172–178
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The median white blood cell (WBC) and lymphocyte levels were lower in patients with COVID- 19 infection (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Based on the fact that Coronavirus Disease 2019 (COVID-19) is associated with many hemocytometric changes, we aimed to investigate the effect of this underlying inflammatory process on the frequency of early pregnancy loss (EPL) in this clinical trial.
📊
Temel Bulgular & Veri:The patients with laboratory-confirmed COVID-19 infection before the 20 weeks of gestation were determined as the study group.
💡
Sonuç & Katkı:The median white blood cell (WBC) and lymphocyte levels were lower in patients with COVID- 19 infection (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Based on the fact that Coronavirus Disease 2019 (COVID-19) is associated with many hemocytometric changes, we aimed to investigate the effect of this underlying inflammatory process on the frequency of early pregnancy loss (EPL) in this clinical trial. Methods: This is a retrospective cohort study. The patients with laboratory-confirmed COVID-19 infection before the 20 weeks of gestation were determined as the study group. Healthy pregnant women in their early pregnancy were determined as the control group. Hematological parameters of all patients included in the analysis were evaluated. Results: A total of 176 pregnant women with confirmed COVID-19 infections were evaluated, of which 117 were included in the analysis. One hundred and seventeen healthy pregnant women were determined as the control group. There was no difference between the groups according to demographic characteristics. The median white blood cell (WBC) and lymphocyte levels were lower in patients with COVID- 19 infection (p

🔖

Bu Makaleye Atıf Yap

ATAK, Z., ÜSTÜNYURT, E., OCAKOĞLU, S. R., UYANIKLAR, Ö. (2022). The effect of COVID-19 infection on hematological parameters and early pregnancy loss. Perinatal journal (Online), Cilt: 30 - Sayı: 2, 172–178. https://ajindex.com/articles/588302

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. CDC. Investigating the impact of COVID-19 during pregnancy. [Internet] Available at: https://www.cdc.gov/coronavirus/ 2019-ncov/cases-updates/special-populations/pregnancy- data-on-covid-19/what-cdc-is-doing.html (accessed May 17, 2022)
  2. Maleki Dana P, Kolahdooz F, Sadoughi F, Moazzami B, Chaichian S, Asemi Z. COVID-19 and pregnancy: a review of current knowledge. Infez Med 2020;28(Suppl 1):46–51. [PubMed] 3. Chi J, Gong W, Gao Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet 2021; 303:337–45. [PubMed] [CrossRef] 4. Wong TC, Lee ZY, Sia TLL, Chang AKW, Chua HH. Miscarriage risk in COVID-19 infection. SN Compr Clin Med 2020;2:1449–52. [PubMed] [CrossRef] 5. WAPM (World Association of Perinatal Medicine) Working Group on COVID-19. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol 2021;57:232–41. [PubMed] [CrossRef] 6. Khalil A, Blakeway H, Samara A, O’Brien P. COVID-19 and stillbirth: direct vs indirect effect of the pandemic. Ultrasound Obstet Gynecol 2022;59:288–95. [PubMed] [CrossRef] 7. Baud D, Greub G, Favre G, Gengler C, Jaton K, Dubruc E, et al. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection. JAMA 2020;323:2198–200. [PubMed] [CrossRef] 8. Khartabil TA, Russcher H, van der Ven A, de Rijke YB. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients. Crit Rev Clin Lab Sci 2020;57: 415–31. [PubMed] [CrossRef] 9. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020;84:106504. [PubMed] [CrossRef] 10. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect 2020;81:e6–e12. [PubMed] [CrossRef] 11. Christoforaki V, Zafeiridiou Z, Daskalakis G, Katassos T, Siristatidis C. First trimester neutrophil to lymphocyte ratio (NLR) and pregnancy outcome. J Obstet Gynaecol 2020;40: 59–64. [PubMed] [CrossRef] 12. Biyik I, Albayrak M, Keskin F. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in missed abortion. Rev Bras Ginecol Obstet 2020;42:235–9. [PubMed] [CrossRef] 13. O¤lak SC, Aydin MF. Are neutrophil to lymphocyte ratio and platelet to lymphocyte ratio clinically useful for the prediction of early pregnancy loss? Ginekol Pol